+8615710194249

News Center

Talk about the development history of mRNA CDMO

2024-01-29

mRNA CDMO (Contract Development and Manufacturing Organization) is a company that provides contract development and manufacturing services, focusing on the development and production of mRNA (messenger ribonucleic acid) technology. The following are key milestones in the history of mRNA CDMO:

1. 2010: With the breakthrough of mRNA technology, * * companies specializing in mRNA research and development and manufacturing were established.

2013: As awareness of the potential of mRNA vaccines increased, mRNA CDMOs began to attract the attention of investors. More companies are entering the market.

3. 2015: * * mRNA vaccine successfully passed clinical trials and was approved for marketing. This milestone marks the beginning of the commercial application of mRNA technology.

4. 2017: With the outbreak of the COVID-19 epidemic, mRNA CDMO companies rose rapidly. They become a key component in making COVID-19 vaccines.

2020: Several mRNA CDMO companies announced the expansion of production capacity to meet global demand for COVID-19 vaccines. This has further promoted the development of mRNA technology.

6. 2021: mRNA CDMO and pharmaceutical giants cooperate to jointly promote the R & D and production of mRNA technology. This collaboration could help accelerate the marketing process for mRNA drugs.

7. Future Outlook: The mRNA CDMO market is expected to continue to grow, and its application in the medical field is expected to further expand. As more research and investment pour in, mRNA CDMOs will continue to play a key role in driving innovation and application of mRNA technology.

These are key milestones in the history of mRNA CDMO, which together have witnessed the rapid development of mRNA technology. As the field of vaccine and drug manufacturing continues to evolve, mRNA CDMOs will continue to play a vital role in medicine.